一种基于抗原喂养树突状细胞来源的抗体工程化外泌体的 CAR-T 启发平台,用于精准实体瘤治疗 A CAR T-inspiring platform based on antibody-engineered exosomes from antigen-feeding dendritic cells for precise solid tumor therapy. PubMed 2022/02/18 发表BiomaterialsQ1 · IF 13.6(JCR 2025) 靶点:EGFR技术:CAR-T技术:外泌体血液系统恶性肿瘤实体瘤地区:中国